Corrigendum to “Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro” [Biomed. Pharmacother. 69 (2015) 402–408](S0753332214002066)(10.1016/j.biopha.2014.12.011);Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro

Biomedicine and Pharmacotherapy

Volumn 69, Issue , 2015, Pages 402-408

  Yang, Fangfang ^a   Yu, Yang ^b   Lei, Qian ^a   Zeng, Anqi ^a   Li, Yali ^a   Xie, Yongmei ^a   Ye, TingHong ^a   Wei, Yuquan ^a  

^a SICHUAN UNIVERSITY   (China)

^b ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Lobaplatin; Melanoma; Migration and invasion

Indexed keywords

LOBAPLATIN; PROTEIN BAX; PROTEIN BCL 2; CYCLOBUTANE DERIVATIVE; PLATINUM COMPLEX;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; M PHASE CELL CYCLE CHECKPOINT; MELANOMA; MELANOMA B16; MELANOMA CELL LINE; MELANOMA METASTASIS; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; CELL CYCLE CHECKPOINT; CELL CYCLE G2 PHASE; CELL DIVISION; CELL MOTION; CELL SHAPE; DRUG EFFECTS; EXPERIMENTAL MELANOMA; METABOLISM; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SHAPE; CYCLOBUTANES; G2 PHASE; MELANOMA, EXPERIMENTAL; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; NEOPLASM INVASIVENESS; ORGANOPLATINUM COMPOUNDS;

EID: 84922254870     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2019.109511     Document Type: Erratum

References (32)

1. DeSantis C.E., Lin C.C., Mariotto A.B., Siegel R.L., Stein K.D., Kramer J.L., et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014, 64:252-271.
2. Howlander N., Noone A., Krapcho M. SEER cancer statistics review, 1975-2011 2014, National Cancer Institute, Bethesda, MD.
3. Chi Z., Li S., Sheng X., Si L., Cui C., Han M., et al. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases. BMC Cancer 2011, 11:85.
4. Cummins D.L., Cummins J.M., Pantle H., Silverman M.A., Leonard A.L., Chanmugam A. Cutaneous malignant melanoma. Mayo Clin Proc 2006, 81:500-507.
5. McKeage M.J. Lobaplatin: a new antitumour platinum drug. Expert Opin Investig Drugs 2001, 10:119-128.
6. Dai H.Y., Liu L., Qin S.K., He X.M., Li S.Y. Lobaplatin suppresses proliferation and induces apoptosis in the human colorectal carcinoma cell line LOVO in vitro. Biomed Pharmacother 2011, 65:137-141.
7. Gietema J.A., de Vries E.G., Sleijfer D.T., Willemse P.H., Guchelaar H.J., Uges D.R., et al. A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days. Br J Cancer 1993, 67:396-401.
8. Fiebig H., Henss H., Mross K., Meyberg F., Aulenbacher P., Burk K., et al. Phase I clinical trial of lobaplatin (D-19466) after intravenous bolus injection. Onkologie 1994, 17:142-148.
9. Wu Q., Qin S.K., Teng F.M., Chen C.J., Wang R. Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells. J Hematol Oncol 2010, 3:43.
10. Wang Z., Tang X., Zhang Y., Qi R., Li Z., Zhang K., et al. Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE. Biomed Pharmacother 2012, 66:161-166.
11. Li X., Ran L., Fang W., Wang D. Lobaplatin arrests cell cycle progression, induces apoptosis and alters the proteome in human cervical cancer cell line CaSki. Biomed Pharmacother 2014, 68:291-297.
12. Voegeli R., Schumacher W., Engel J., Respondek J., Hilgard P. D-19466, a new cyclobutane-platinum complex with antitumor activity. J Cancer Res Clin Oncol 1990, 116:439-442.
13. Ye T., Xiong Y., Yan Y., Xia Y., Song X., Liu L., et al. The anthelmintic drug niclosamide induces apoptosis, impairs metastasis and reduces immunosuppressive cells in breast cancer model. PLOS ONE 2014, 9:e85887.
14. Zhu Y., Xia Y., Ye T., Shi X., Song X., Liu L., et al. A novel small-molecule YLT205 induces apoptosis in human colorectal cells via mitochondrial apoptosis pathway in vitro and inhibits tumor growth in vivo. Cell Physiol Biochem 2014, 33:933-944.
15. Gaul C., Njardarson J.T., Shan D., Dorn D.C., Wu K.D., Tong W.P., et al. The migrastatin family: discovery of potent cell migration inhibitors by chemical synthesis. J Am Chem Soc 2004, 126:11326-11337.
16. Zhang T., Li J., Dong Y., Zhai D., Lai L., Dai F., et al. Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion. Breast Cancer Res Treat 2012, 135:445-458.
17. Ye T., Wei X., Yin T., Xia Y., Li D., Shao B., et al. Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasis. Breast Cancer Res Treat 2014, 143:435-446.
18. Ge Z.-H., Wang Z.-X., Yu T.-L., Yang N., Sun Y., Hao C.-L., et al. Morphine improved the antitumor effects on MCF-7 cells in combination with 5-fluorouracil. Biomed Pharmacother 2014, 68:299-305.
19. Duncan L.M., Deeds J., Hunter J., Shao J., Holmgren L.M., Woolf E.A., et al. Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res 1998, 58:1515-1520.
20. Steeg P.S. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006, 12:895-904.
21. Tsuruo T., Naito M., Tomida A., Fujita N., Mashima T., Sakamoto H., et al. Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sci 2003, 94:15-21.
22. 1 phase arrest and apoptosis in human hepatic carcinoma cells. Biochem Biophys Res Commun 2012, 421:684-689.
23. Fesik S.W. Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer 2005, 5:876-885.
24. Zhang W., Konopleva M., Ruvolo V., McQueen T., Evans R., Bornmann W., et al. Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway. Leukemia 2008, 22:808-818.
25. Autret A., Martin S.J. Emerging role for members of the Bcl-2 family in mitochondrial morphogenesis. Mol Cell 2009, 36:355-363.
26. m) in apoptosis; an update. Apoptosis 2003, 8:115-128.
27. Pasetto L.M., D'Andrea M.R., Brandes A.A., Rossi E., Monfardini S. The development of platinum compounds and their possible combination. Crit Rev Oncol Hematol 2006, 60:59-75.
28. Voland C., Bord A., Péleraux A., Pénarier G., Carrière D., Galiègue S., et al. Repression of cell cycle-related proteins by oxaliplatin but not cisplatin in human colon cancer cells. Mol Cancer Ther 2006, 5:2149-2157.
29. Gray-Schopfer V., Wellbrock C., Marais R. Melanoma biology and new targeted therapy. Nature 2007, 445:851-857.
30. Hodi F.S., O'Day S.J., McDermott D.F., Weber R.W., Sosman J.A., Haanen J.B., et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010, 363:711-723.
31. Friedl P., Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003, 3:362-374.
32. Kuratomi Y., Nomizu M., Tanaka K., Ponce M.L., Komiyama S., Kleinman H.K., et al. Laminin gamma 1 chain peptide, C-16 (KAFDITYVRLKF), promotes migration, MMP-9 secretion, and pulmonary metastasis of B16-F10 mouse melanoma cells. Br J Cancer 2002, 86:1169-1173.